Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA.
Department of Surgery, University of Utah, Salt Lake City, UT, USA.
Am J Surg. 2024 Apr;230:43-46. doi: 10.1016/j.amjsurg.2023.11.036. Epub 2023 Nov 29.
We seek to determine the association between COVID-19 diagnosis and postoperative outcomes following bariatric surgery.
Using the Metabolic and Bariatric Surgery Accreditation Quality Improvement Project (MBSAQIP) database, patients undergoing sleeve gastrectomy and gastric bypass without a COVID-19 diagnosis were 2:1 propensity-score matched to those with COVID-19 infection pre or postoperatively.
1369 (0.74 %) and 1331 (0.72 %) patients had a COVID-19 diagnosis within 14 days prior to or 30 days after their operation, respectively. Patients with preoperative COVID-19 infection had equivalent outcomes to COVID-19 negative patients (all p > 0.05). Postoperative COVID-19 diagnosis was associated with worse outcomes including increased risk of anastomotic/staple line leak (1.1 % vs 0.1 %, p < 0.001), postoperative pneumonia (2.9 % vs 0.1 %, p < 0.001), and 30-day reoperation (2.1 % vs 0.9 %, p = 0.002).
Postoperative diagnosis of COVID-19 after bariatric surgery is associated with worse outcomes; however, it is safe to perform these procedures on patients recently convalesced from COVID-19 infection.
我们旨在确定 COVID-19 诊断与减重手术后结局之间的关联。
利用代谢和减重手术认证质量改进项目（MBSAQIP）数据库，将术前或术后无 COVID-19 诊断的袖状胃切除术和胃旁路术患者按 2:1 比例与 COVID-19 感染患者进行倾向评分匹配。
分别有 1369 例（0.74%）和 1331 例（0.72%）患者在手术前 14 天内或手术后 30 天内被诊断为 COVID-19。术前 COVID-19 感染患者的结局与 COVID-19 阴性患者相当（均 p>0.05）。术后 COVID-19 诊断与更差的结局相关，包括吻合口/吻合线漏的风险增加（1.1%比 0.1%，p<0.001）、术后肺炎（2.9%比 0.1%，p<0.001）和 30 天再次手术（2.1%比 0.9%，p=0.002）。
减重手术后 COVID-19 的术后诊断与更差的结局相关；然而，对最近从 COVID-19 感染中康复的患者进行这些手术是安全的。
